Literature DB >> 24967888

Of MIs and men--a historical perspective on the diagnostics of acute myocardial infarction.

Gianfranco Cervellin1, Giuseppe Lippi2.   

Abstract

The history of myocardial infarction (MI) diagnostics has gone through a continuous evolution over the past century, when several new discoveries have contributed to remarkably increase the number of patients appropriately diagnosed with this condition. The tale "of MIs and Men" displays rather a long history, since atherosclerosis was found to be present in humans several centuries before modern civilization and the identification of the most prevalent risk factors. It was only at the end of the 19th century and at the beginning of the 20th century that the physicians acknowledged that MI is principally sustained by coronary thrombosis, and that the clinical picture of MI could be subsequently confirmed at autopsy. With the first description of the electrocardiogram (ECG) in the 1910s and 1920s, the history of modern MI diagnostics really began. Additional important discoveries followed, which are mainly represented by radiography, echocardiography, computed tomography, and magnetic resonance imaging of the heart. Another major breakthrough occurred at the down of the third millennium, with the development of commercial immunoassays for the measurement of cardiac troponin I and T, which represent now the cornerstones for identifying any kind of myocardial injury, thus including MI. The major advancements in the understanding of MI pathophysiology and the progressive introduction of efficient diagnostic tools will be described and discussed in this narrative historical review. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24967888     DOI: 10.1055/s-0034-1383544

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  14 in total

1.  Biomarkers: Novel troponin immunoassay for early ACS rule-out.

Authors:  Giuseppe Lippi
Journal:  Nat Rev Cardiol       Date:  2015-12-03       Impact factor: 32.419

2.  Evidence and pitfalls in diagnosis and prognostication of acute coronary syndrome.

Authors:  Giuseppe Lippi; Gianfranco Cervellin
Journal:  Ann Transl Med       Date:  2016-07

3.  Predictive significance of detectable cardiac troponin I measured with a contemporary-sensitive assay in a real life experience.

Authors:  Laura Bonfanti; Giuseppe Lippi; Irene Ciullo; Tiziana Meschi; Andrea Ticinesi; Rosalia Aloe; Francesco Di Spigno; Gianfranco Cervellin
Journal:  Ann Transl Med       Date:  2016-07

Review 4.  Diagnostic algorithms for acute coronary syndrome-is one better than another?

Authors:  Gianfranco Cervellin; Camilla Mattiuzzi; Chiara Bovo; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2016-05

5.  Acute coronary syndrome: many doubts, some answers.

Authors:  Giuseppe Lippi; Gianfranco Cervellin
Journal:  Ann Transl Med       Date:  2016-05

6.  Troubleshooting an isolate prolongation of activated partial thromboplastin time in a patient with acute myocardial infarction-a paradigmatic case report.

Authors:  Giovanni Poli; Piero Castiglioni; Martina Montagnana; Emmanuel J Favaloro; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2016-11

7.  Red blood cell distribution width independently predicts medium-term mortality and major adverse cardiac events after an acute coronary syndrome.

Authors:  Gianni Turcato; Valentina Serafini; Alice Dilda; Chiara Bovo; Beatrice Caruso; Giorgio Ricci; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2016-07

Review 8.  High-sensitivity cardiac troponin testing in routine practice: economic and organizational advantages.

Authors:  Claudio Galli; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2016-07

Review 9.  Epidemiology of coronary heart disease and acute coronary syndrome.

Authors:  Fabian Sanchis-Gomar; Carme Perez-Quilis; Roman Leischik; Alejandro Lucia
Journal:  Ann Transl Med       Date:  2016-07

Review 10.  The clinics of acute coronary syndrome.

Authors:  Gianfranco Cervellin; Gianni Rastelli
Journal:  Ann Transl Med       Date:  2016-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.